RBC Europe’s Ocugen OCGN Stock Holding History

RBC Europe’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-25,000	Closed	-$180K	–	971
2021 Q3	$180K	Hold	25,000	–	–	0.01%	318
2021 Q2	$201K	Buy	+25,000	New	+$211K	0.01%	311

Other funds holding OCGN

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

RBC Europe's OCGN Position: Q4 2021 in Review

RBC Europe sold out of Ocugen (OCGN) in Q4 2021, closing a stake of 25,000 shares — an estimated $180K sold.

RBC Europe first reported a position in OCGN in Q2 2021 and held it in 2 quarters. The position peaked at $201K in Q2 2021. 122 funds tracked by Wall St. Rank hold OCGN as of Q4 2021.

RBC Europe reported no remaining Ocugen position as of Q4 2021 after selling out during the quarter.
RBC Europe sold 25,000 Ocugen shares in Q4 2021, an estimated $180K.
RBC Europe first reported a position in Ocugen in Q2 2021 and held it in 2 quarters.
RBC Europe's Ocugen position peaked at $201K in Q2 2021.
122 funds tracked by Wall St. Rank held Ocugen as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.